| Titre : | Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data - the ANRS-Coquelicot Study |
| Auteurs : | M. JAUFFRET-ROUSTIDE ; J. EMMANUELLI ; M. QUAGLIA ; F. BARIN ; P. ARDUIN ; A LAPORTE ; J. C. DESENCLOS |
| Type de document : | Périodique |
| Année de publication : | 2006 |
| Format : | 1603-1621 |
| Note générale : |
Substance Use and Misuse, 2006, 41, (10-12), 1603-1621 |
| Langues: | Français |
| Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
| Mots-clés : |
Thésaurus TOXIBASE VIH ; POLITIQUE ; EPIDEMIOLOGIE ; ENQUETE ; REDUCTION DES RISQUES ; HEPATITE ; ETUDE TRANSVERSALE ; PREVALENCE ; INFECTIONThésaurus Géographique FRANCE |
| Résumé : |
ENGLISH : In France a harm-reduction policy was implemented in the late 1980s with the aim of reducing the prevalence of HIV and hepatitis C virus (HCV) infection among drug users. The ANRS-Coquelicot survey was designed to measure the prevalence of HIV and HCV infection among drug users and to examine determinants of at-risk behaviors. In 2002, information was collected from 166 drug users recruited in all types of services specializing in drug use intervention and harm reduction in Marseille, France. Self-reported HIV and HCV serostatus was compared with the results of serological tests done on capillary blood collected on filter paper. The self-reported and biologically documented prevalence rates of HIV infection were identical (22%). In contrast, the self-reported prevalence of HCV infection was 52%, whereas the biologically documented prevalence was 73%. Overall, 30% of HCV-infected drug users were unaware of their status. Forty-four percent of drug users under 30 years of age were HCV seropositive, suggesting that they had been infected early during drug use. The harm-reduction policy seems to have had a marked impact on HIV transmission among drug users but a much more limited impact on HCV transmission. The limitations and implications of the study are discussed. (Author' s abstract) |
| Domaine : | Drogues illicites / Illicit drugs |
| Affiliation : | National Institute for Public Health Surveillance, Saint-Maurice. Email : m.jauffret@invs.sante.fr France. France. |
| Centre Emetteur : | 13 OFDT |
| Cote : | A02975 |
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
